0001827506-24-000063.txt : 20240627
0001827506-24-000063.hdr.sgml : 20240627
20240627081228
ACCESSION NUMBER: 0001827506-24-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240625
FILED AS OF DATE: 20240627
DATE AS OF CHANGE: 20240627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robinson Ryan F.
CENTRAL INDEX KEY: 0001997834
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 241075419
MAIL ADDRESS:
STREET 1: C/O TOURMALINE BIO, INC.
STREET 2: 27 WEST 24TH STREET, SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tourmaline Bio, Inc.
CENTRAL INDEX KEY: 0001827506
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27 WEST 24TH STREET
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 646-481-9832
MAIL ADDRESS:
STREET 1: 27 WEST 24TH STREET
STREET 2: SUITE 702
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: Talaris Therapeutics, Inc.
DATE OF NAME CHANGE: 20201007
4
1
wk-form4_1719490341.xml
FORM 4
X0508
4
2024-06-25
0
0001827506
Tourmaline Bio, Inc.
TRML
0001997834
Robinson Ryan F.
C/O TOURMALINE BIO, INC.
27 WEST 24TH STREET, SUITE 702
NEW YORK
NY
10010
0
1
0
0
Chief Financial Officer
0
Employee Stock Option (Right to Buy)
14.21
2024-06-25
4
A
0
76400
0
A
2034-06-24
Common Stock
76400
76400
D
The shares subject to the option vest as to 25% of the shares on October 18, 2024 with the remainder vesting in 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
/s/ Brad Middlekauff, Attorney-in-Fact
2024-06-27